23 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18576610 | ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN | FAY, ZOHREH ALEMZADEH | 1617 | Non-Final OA | Jan 04, 2024 |
| 18251827 | PHARMACEUTICAL COMPOSITION FOR TREATING LEUKEMIA COMPRISING FLT3 INHIBITOR | WEDDINGTON, KEVIN E | 1629 | Non-Final OA | Dec 12, 2023 |
| 18549622 | BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS | CHONG, YONG SOO | 1623 | Non-Final OA | Sep 08, 2023 |
| 18036538 | USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF NEUROPATHY CAUSED BY OR ACCOMPANIED BY FABRY DISEASE | JONES-FOSTER, ERICA NICOLE | 1656 | Non-Final OA | May 11, 2023 |
| 18036580 | USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF RENAL DISEASES CAUSED BY OR ACCOMPANIED BY FABRY DISEASE | JONES-FOSTER, ERICA NICOLE | 1656 | Non-Final OA | May 11, 2023 |
| 18031940 | PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING LUPUS-RELATED DISEASES | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Apr 14, 2023 |
| 18032076 | PHARMACEUTICAL COMPOSITION COMPRISING GLUCAGON/GLP-1/GIP TRIPLE AGONIST OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING VASCULITIS | KATAKAM, SUDHAKAR | 1658 | Final Rejection | Apr 14, 2023 |
| 18028420 | THERAPEUTIC USE, FOR NEURODEGENERATIVE DISEASES, OF TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS, OR CONJUGATE THEREOF | HUYNH, PHUONG N | 1641 | Non-Final OA | Mar 24, 2023 |
| 18028424 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES, COMPRISING TRIPLE AGONIST OR CONJUGATE THEREOF HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1 AND GLP RECEPTORS | XIE, XIAOZHEN | 1674 | Non-Final OA | Mar 24, 2023 |
| 18040869 | PHARMACEUTICAL COMPOSITION COMPRISING LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST | CHANDRA, GYAN | 1674 | Final Rejection | Feb 07, 2023 |
| 18016165 | THERAPEUTIC USE OF GLUCAGON DERIVATIVE OR CONJUGATE THEREOF FOR LIVER DISEASE | ROSSI, JULIA ANNE LORRAIN | 1615 | Final Rejection | Jan 13, 2023 |
| 18016145 | THERAPEUTIC USE OF COMBINATION COMPRISING TRIPLE AGONISTIC LONG-ACTING CONJUGATE OR TRIPLE AGONIST | CHANDRA, GYAN | 1674 | Non-Final OA | Jan 13, 2023 |
| 17927150 | LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLUCAGON DERIVATIVE | CHANDRA, GYAN | 1674 | Non-Final OA | Nov 22, 2022 |
| 17927257 | LIQUID FORMULATION | CARTER, SANDRA DILLAHUNT | 1674 | Non-Final OA | Nov 22, 2022 |
| 17926912 | LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLUCAGON, GLP-1, AND GIP TRIGONAL AGONIST | ROSSI, JULIA ANNE LORRAIN | 1615 | Final Rejection | Nov 21, 2022 |
| 17915976 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF, COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAME | BRADLEY, CHRISTINA | 1654 | Non-Final OA | Sep 29, 2022 |
| 17880358 | IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRN | DAHLE, CHUN WU | 1641 | Final Rejection | Aug 03, 2022 |
| 17788488 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC BONE DISEASES, COMPRISING GLP-2 OR CONJUGATE THEREOF | SABILA, MERCY HELLEN | 1654 | Non-Final OA | Jun 23, 2022 |
| 17839053 | METHOD FOR IMPROVING SOLUBILITY OF PROTEIN AND PEPTIDE BY USING IMMUNOGLOGULIN FC FRAGMENT LINKAGE | REYNOLDS, FRED H | 1658 | Final Rejection | Jun 13, 2022 |
| 17766137 | COMPOSITION COMPRISING GLUCAGON AND GLP-1 AND GIP RECEPTOR DUAL AGONIST AND THERAPEUTIC USE OF SAME | HELLMAN, KRISTINA M | 1654 | Final Rejection | Apr 01, 2022 |
| 17700055 | TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST | FISCHER, JOSEPH | 1658 | Non-Final OA | Mar 21, 2022 |
| 17416880 | A PHARMACEUTICAL COMPOSITION COMPRISING INSULIN AND TRIGONAL GLUCAGON/GLP-1/GIP RECEPTOR AGONIST | SABILA, MERCY HELLEN | 1654 | Final Rejection | Jun 21, 2021 |
| 17282661 | THERAPEUTIC USE OF GLUCAGON AND COMBINATION INCLUDING THE SAME | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Final Rejection | Apr 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial